Our Services and Platform Technologies
RxCelerate offer access to world class platform technologies and a complete range of services from early in silico discovery through to preclinical studies. Find out more below.
Our Platform Technologies
Antibody Discovery Platform
Proprietary human antibody discovery platform, which combines the biology of B-cell selection and in vitro methodologies to maximise diversity and find high quality leads.
Dynamic Chemical Space
First commercially available dynamic chemical space allowing in silico screening of billions of novel small molecules against a target in a matter of weeks.
Proteomics Platform
Unique proteomics platform offering quantitative precision and unbiased analysis of proteins and their modifications in simple and complex matrices.
Our Services
In Silico Drug Discovery
Cutting-edge in silico discovery and development of small molecule therapeutics, antibodies and biopharmaceuticals, plus enzyme engineering. Home of RxNfinity, the chemical space exploration platform.
ANTIBODY DISCOVERY
Isolation of fully human antibodies using our ‘Galaxy’ platform.
Immune library generation & humanisation expertise.
Project and Programme Management
Client focused project management, driven by best practices, with experienced project managers that can input at all stages from concept to clinic.
Early-Stage Chemistry and CMC
Generation of high quality hit material, development candidates, and active pharmaceutical ingredients as quickly and cost-effectively as possible.
IN VITRO services
In vitro assay design and development including cell-based and plate-based assays, molecular and biochemical assays and ICC.
DROSOPHILA services
Design and development of assays using Drosophila melanogaster, enabling drug screening in a whole organism with a quick turnaround.
In Vivo Services
Complete in vivo and histology services covering a wide range of disease areas and therapeutic approaches.
GLP & GCP Bioanalytical Services
Providing bespoke in-house assays and analytical methods including PK, ADME and stability studies, with GCP and GLP accreditation for regulated studies.